Nos publications
Experience foam for topical drug delivery
nov 2016
Pharmaceutical foams are becoming more popular probably due to more topical medicines being switched to OTC and the need to innovate and differentiate ‘brands’ and an increasing awareness of the importance of formulating to deliver sensorial benefits and positive impact on patient experience and adherence. Gattefossé, as a leading provider of excipients for the pharmaceutical industry, manufactures solubilizers and texturizers for skin drug delivery. In this white paper we give formulation tips for propellant and propellant-free foams with guidelines on how to formulate and select excipients and case studies with model drugs.
Converting light emulsion into a creamy foam for psoriasis treatment. A case study with betamethasone dipropionate
AAPS Annual Meeting & Exposition – Denver (USA) - nov 2016
Converting simple microemulsion into attractive foam for topical pain treatment. A case study with lidocaine base
AAPS Annual Meeting & Exposition – Denver (USA) - nov 2016
Pharmaceutical foams with optimized microemulsion and propellant-free pump
PBP World Meeting 2016 – Glasgow (Scotland) - avr 2016